Medtronic plc. (MDT) EVP Bryan C. Hanson Sells 16,000 Shares

Medtronic plc. (NYSE:MDT) EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $82.82, for a total transaction of $1,325,120.00. Following the completion of the transaction, the executive vice president now owns 88,818 shares of the company’s stock, valued at $7,355,906.76. The sale was disclosed in a filing with the SEC, which is available at this link.

Bryan C. Hanson also recently made the following trade(s):

  • On Thursday, November 16th, Bryan C. Hanson sold 16,000 shares of Medtronic stock. The stock was sold at an average price of $79.02, for a total transaction of $1,264,320.00.

Medtronic plc. (MDT) traded down $0.28 during trading hours on Friday, reaching $85.45. 5,085,912 shares of the company’s stock were exchanged, compared to its average volume of 4,960,000. The company has a market cap of $116,040.00, a price-to-earnings ratio of 23.48, a P/E/G ratio of 2.35 and a beta of 0.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40. Medtronic plc. has a 1-year low of $73.59 and a 1-year high of $89.72.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.08. The business had revenue of $7.05 billion during the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. Medtronic’s revenue was down 4.0% compared to the same quarter last year. During the same period last year, the business earned $1.12 EPS. sell-side analysts anticipate that Medtronic plc. will post 4.77 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend is Thursday, December 28th. Medtronic’s payout ratio is presently 50.55%.

Several brokerages recently issued reports on MDT. Stifel Nicolaus increased their price target on shares of Medtronic from $83.00 to $85.00 and gave the stock a “hold” rating in a research note on Wednesday, November 22nd. Oppenheimer reiterated a “buy” rating and issued a $94.00 price target on shares of Medtronic in a research note on Wednesday, November 22nd. Northland Securities reiterated a “hold” rating and issued a $80.00 price target on shares of Medtronic in a research note on Wednesday, November 22nd. Zacks Investment Research upgraded shares of Medtronic from a “sell” rating to a “hold” rating in a research note on Thursday, November 23rd. Finally, Jefferies Group reiterated a “buy” rating and issued a $99.00 price target on shares of Medtronic in a research note on Thursday, November 23rd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. Medtronic presently has a consensus rating of “Buy” and an average target price of $89.65.

Several hedge funds and other institutional investors have recently made changes to their positions in MDT. Westside Investment Management Inc. boosted its holdings in shares of Medtronic by 114.5% during the 1st quarter. Westside Investment Management Inc. now owns 13,476 shares of the medical technology company’s stock valued at $1,081,000 after acquiring an additional 7,193 shares during the last quarter. Israel Discount Bank of New York purchased a new stake in shares of Medtronic during the 1st quarter valued at about $117,000. Sentry Investments Corp. boosted its holdings in shares of Medtronic by 0.5% during the 1st quarter. Sentry Investments Corp. now owns 1,093,500 shares of the medical technology company’s stock valued at $88,092,000 after acquiring an additional 5,100 shares during the last quarter. SRS Capital Advisors Inc. boosted its holdings in shares of Medtronic by 16.6% during the 1st quarter. SRS Capital Advisors Inc. now owns 2,302 shares of the medical technology company’s stock valued at $185,000 after acquiring an additional 327 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in shares of Medtronic by 3.3% during the 1st quarter. Legal & General Group Plc now owns 6,895,339 shares of the medical technology company’s stock valued at $555,494,000 after acquiring an additional 217,257 shares during the last quarter. 81.72% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Medtronic plc. (MDT) EVP Bryan C. Hanson Sells 16,000 Shares” was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2018/01/13/insider-selling-medtronic-plc-mdt-evp-sells-1325120-00-in-stock.html.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Insider Buying and Selling by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply